missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PDCD4 Antibody, Novus Biologicals™
  7. 18671216

PDCD4 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP2-98857-100ul

 View more versions of this product

Product Code. 18671216

  • € 326.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

PDCD4 Polyclonal antibody specifically detects PDCD4 in Human samples. It is validated for Immunocytochemistry/ Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PDCD4
Polyclonal
Immunocytochemistry/ Immunofluorescence 1:300-1:10000
H731nuclear antigen H731, MGC33046, MGC33047, Neoplastic transformation inhibitor protein, Nuclear antigen H731-like, programmed cell death 4 (neoplastic transformation inhibitor), programmed cell death protein 4, Protein 197/15a
Produced in rabbits immunized with a synthetic peptide corresponding to the center region of the Human PDCD4.
100 μg
Apoptosis
27250
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG
Immunofluorescence
Unconjugated
0.2 um filtered solution in PBS
Rabbit
Antigen and protein A Affinity-purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.